ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

VKTXW Viking Therapeutics Inc

4,60
0,00 (0,00%)
31 Mai 2024 - Fermé
Retardé de 15 minutes
Quarter End Juin 2022Sept 2022Déc 2022Mar 2023Juin 2023Sept 2023Déc 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Revenu total 00000000
Revenu d'exploitation -17,63M-16,2M-20,28M-20,54M-23,74M-27,27M-29,29M-34,07M
Revenu avant impôt -17,43M-15,77M-19,56M-19,53M-19,23M-22,53M-24,61M-27,36M
Revenu net -17,43M-15,77M-19,56M-19,53M-19,23M-22,53M-24,61M-27,36M
Dividendes privilégiés 00000000
Résultat de base par action 00000000
EBIT -17,63M-16,2M-20,28M-20,54M-23,74M-27,27M-29,29M-34,07M
EBITDA -17,63M-16,2M-20,28M-20,54M-23,74M-27,27M-29,29M-34,07M
Fin d'année 31 Décembre 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Revenu total 00000000
Revenu d'exploitation -13,85M-19,07M-26,16M-32,69M-42,66M-55,68M-70,36M-100,83M
Revenu avant impôt -14,73M-20,58M-22,06M-25,78M-39,5M-54,99M-68,87M-85,9M
Revenu net -14,73M-20,58M-22,06M-25,78M-39,5M-54,99M-68,87M-85,9M
Dividendes privilégiés 00000000
Résultat de base par action -0.707-0.575-0.308-0.356-0.539-0.703-0.905-0.859
EBIT -14,71M-20,58M-25,29M-32,83M-42,77M-55,7M-70,36M-100,83M
EBITDA -13,85M-19,07M-26,16M-32,69M-42,66M-55,68M-70,36M-100,83M